Chronic Lyme disease: misconceptions and challenges for patient management
Author:
Open Access
- 1 May 2015
- journal article
- review article
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 8, 119-128
Abstract
Chronic Lyme disease: misconceptions and challenges for patient management John J HalperinDepartment of Neurosciences, Overlook Medical Center, Summit, NJ, USA Lyme disease, infection with the tick-borne spirochete Borrelia burgdorferi, causes both specific and nonspecific symptoms. In untreated chronic infection, specific manifestations such as a relapsing large-joint oligoarthritis can persist for years, yet subside with appropriate antimicrobial therapy. Nervous system involvement occurs in 10%–15% of untreated patients and typically involves lymphocytic meningitis, cranial neuritis, and/or mononeuritis multiplex; in some rare cases, patients have parenchymal inflammation in the brain or spinal cord. Nervous system infection is similarly highly responsive to antimicrobial therapy, including oral doxycycline. Nonspecific symptoms such as fatigue, perceived cognitive slowing, headache, and others occur in patients with Lyme disease and are indistinguishable from comparable symptoms occurring in innumerable other inflammatory states. There is no evidence that these nonspecific symptoms reflect nervous system infection or damage, or that they are in any way specific to or diagnostic of this or other tick-borne infections. When these symptoms occur in patients with Lyme disease, they typically also subside after antimicrobial treatment, although this may take time. Chronic fatigue states have been reported to occur following any number of infections, including Lyme disease. The mechanism underlying this association is unclear, although there is no evidence in any of these infections that these chronic posttreatment symptoms are attributable to ongoing infection with B. burgdorferi or any other identified organism. Available appropriately controlled studies indicate that additional or prolonged courses of antimicrobial therapy do not benefit patients with a chronic fatigue-like state after appropriately treated Lyme disease. Keywords: Lyme disease, Borrelia burgdorferi, chronic, diagnosis, treatment, chronic fatigue, neuroborreliosisKeywords
This publication has 63 references indexed in Scilit:
- Prospective Validation of a Clinical Prediction Model for Lyme Meningitis in ChildrenPediatrics, 2009
- Prediction of Lyme Meningitis Based on a Logistic Regression Model Using Clinical and Cerebrospinal Fluid AnalysisThe Pediatric Infectious Disease Journal, 2009
- The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosisJournal of Neuroinflammation, 2009
- Successful Treatment of Lyme Encephalopathy with Intravenous CeftriaxoneThe Journal of Infectious Diseases, 1999
- Borrelia burgdorferi ‐specific intrathecal antibody production in neuroborreliosisNeurology, 1993
- Lyme neuroborreliosis: A new sensitive diagnostic assay for intrathecal synthesis of borrelia burgdorferi–specific immunoglobulin G, A, and MAnnals of Neurology, 1991
- Seronegative Lyme DiseaseNew England Journal of Medicine, 1988
- Progressive Borrelien-Enzephalomyelitis: Chronische Manifestation der Erythema-chronicum-migrans-Krankheit am NervensystemDMW - Deutsche Medizinische Wochenschrift, 1985
- Spirochetes Isolated from the Blood of Two Patients with Lyme DiseaseNew England Journal of Medicine, 1983
- The Spirochetal Etiology of Lyme DiseaseNew England Journal of Medicine, 1983